Literature DB >> 24040725

Hepatitis B in Poland in 2011.

Małgorzata Stepień1, Mirosław P Czarkowski.   

Abstract

OBJECTIVES: Evaluation of the epidemiological situation of hepatitis B in Poland in 2011 in comparison with previous years.
MATERIALS AND METHODS: Evaluation of occurrence of hepatitis B in Poland, registered in 2011, based on the results of the analysis of case-based data for acute hepatitis B sent to the NIPH-NIH by the State Sanitary Inspection and on aggregate data from annual bulletin "Infectious diseases and poisonings in Poland".
RESULTS: A total of 1,583 hepatitis B cases, including 30 cases of co-infection with hepatitis C (HCV) was reported in 2011. Incidence was 4.11 per 100,000 population and was lower by 4% compared to the previous year. Acute cases constituted 6.6% of all hepatitis B cases, the incidence - 0.27 per 100,000 population. The highest incidence of acute hepatitis B recorded in Podlaskie (1.00 per 100,000 population) and that of chronic in Opolskie (10.83 per 100,000). Overall, hepatitis B occurred more often in males than females and those residing in urban areas. Chronic hepatitis B was most frequently detected (as in previous years) in people aged 15-19, most rarely in those aged 0-14 entirely covered by universal HBV vaccination of infants. The highest incidence of acute hepatitis B was observed among people aged 30-34 (0.64 per 100,000) and among those aged 65-74 (0.58 per 100,000). Predominant route of infection hepatitis B in Poland were medical procedures (in 55% of all acute cases). Among young people (aged 25-34) have been observed increasing share of infections acquired through sexual contact or intravenous drug use (28% of acute cases), among elderly people nonmedical routes of infection constituted only 7% and mostly it was the contact with infected household member. In 2011, eight people died because of acute hepatitis B and 40 due to chronic hepatitis B.
CONCLUSIONS: Observed steady downward trend in incidence of acute hepatitis B indicates persistent effectiveness of the universal HBV vaccination program. In view of growing share of acute cases acquired by sexual transmission or drug use it is reasonable to recommend vaccinations to unvaccinated at-risk people especially those exposed to HBV infection due to lifestyle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24040725

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  4 in total

1.  High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia.

Authors:  Susan Irawati Ie; Erick Sidarta; Arkasha Sadhewa; Gludhug Ariyo Purnomo; Yuyun S M Soedarmono; Mochtar Zein Pattiiha; Meta Dewi Thedja; Alida R Harahap; David H Muljono
Journal:  Am J Trop Med Hyg       Date:  2015-09-21       Impact factor: 2.345

2.  Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013.

Authors:  Barbara Stawinska-Witoszynska; Monika Zysnarska; Małgorzata Krzywinska-Wiewiorowska; Paulina Wojtyła-Buciorab; Alicja Krzyzaniak; Barbara Wieckowska
Journal:  Hepat Mon       Date:  2016-07-25       Impact factor: 0.660

3.  Distribution of HBV genotypes in Poland.

Authors:  Magdalena Świderska; Małgorzata Pawłowska; Włodzimierz Mazur; Krzysztof Tomasiewicz; Krzysztof Simon; Anna Piekarska; Marta Wawrzynowicz-Syczewska; Jerzy Jaroszewicz; Paweł Rajewski; Ewelina Zasik; Elżbieta Murias-Bryłowska; Anna Pniewska; Waldemar Halota; Robert Flisiak
Journal:  Clin Exp Hepatol       Date:  2015-04-30

Review 4.  Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia).

Authors:  Bela Hunyady; Jerzy Jaroszewicz; Ľubomír Lipták; Ľubomír Skladaný; Jan Sperl; Juraj Šváč
Journal:  Clin Exp Hepatol       Date:  2016-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.